ProfileGDS4132 / 233121_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 45% 47% 37% 39% 40% 40% 45% 37% 42% 38% 42% 39% 36% 35% 37% 41% 38% 43% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101110.78942
GSM201543Muscle PCOS pioglitazone 121110.34845
GSM201544Muscle PCOS pioglitazone 161125.67247
GSM201545Muscle PCOS pioglitazone 201103.64637
GSM201829Muscle PCOS pioglitazone 231108.26339
GSM201830Muscle PCOS pioglitazon 251108.29540
GSM201831Muscle PCOS pioglitazone 271103.99640
GSM201832Muscle PCOS pioglitazone 31117.9845
GSM201833Muscle PCOS pioglitazone 4189.698837
GSM201834Muscle PCOS pioglitazone 81106.97942
GSM201835Muscle PCOS after pioglitazone 10282.660138
GSM201836Muscle PCOS after pioglitazone 12297.402842
GSM201837Muscle PCOS after pioglitazone 16285.700439
GSM201838Muscle PCOS after pioglitazone 20281.193836
GSM201839Muscle PCOS after pioglitazone 23282.669735
GSM201840Muscle PCOS after pioglitazone 25288.998337
GSM201841Muscle PCOS after pioglitazone 27291.962641
GSM201842Muscle PCOS after pioglitazone 3278.368438
GSM201843Muscle PCOS after pioglitazone 42107.51943
GSM201844Muscle PCOS after pioglitazone 8291.432838